Current News
The combination between biochemical and cell based assay- Attana appears in International Trade News
News Mar 02, 2012 09:15 EST
Long before pharmaceutical substances are tried on animals or human beings, they are carefully tested in simulated environments. Attana's biosensors characterize molecular interactions exactly as they would occur in the human body, the company offers its clients relevant information before further tests are carried out.
Find out: Why bridge the existing gap between biochemical and cell based assays?
News Nov 16, 2011 09:32 EST
One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.
Pictures
Videos
-
Attana on Today in America
Attana is featured in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to “Improving Diagnostic Outcomes through Biosensor Technology” as part of the show’s “Medical Minutes” series. In the clip we find out why biological relevance is important and how it is possible to shorten the time between research initiation and new drug on the market.
-
Attana Cell Biosensor
Attana Cell 200 biosensor has the unique ability to determine label-free kinetics directly on the cell surface, therefore disclosing the full complexity of the interaction at a very early stage. By delivering biologically relevant information this early in the research process, the Attana Cell 200 minimizes costs and increases success during clinical trials. (produced by TTV AB)
-
Antibody - Antigen Characterization
This movie shows Monoclonal Antibody - Antigen Characterization and provides information on Kinetics & Affinity, Selection, Specificity and Concentration using the Attana Quartz Crystal Microbalance systems. www. attana.com
